John G Ullman & Associates Inc Becton Dickinson & CO Transaction History
John G Ullman & Associates Inc
- $631 Million
- Q4 2024
A detailed history of John G Ullman & Associates Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, John G Ullman & Associates Inc holds 26,250 shares of BDX stock, worth $5.4 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
26,250
Previous 1,121
2241.66%
Holding current value
$5.4 Million
Previous $270,000
2105.56%
% of portfolio
0.94%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BDX
# of Institutions
1,811Shares Held
259MCall Options Held
1.2MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.5 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.58 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$2.9 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.54 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.49 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $58.7B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...